Shares of Utah Medical Products, Inc. UTMD have declined 3% since the company reported its earnings for the quarter ended June 30, 2025. This compares to the S&P 500 index’s 0.6% growth over the same...
Shares of Utah Medical Products, Inc. UTMD have gained 0.8% since the company reported its earnings for the quarter ended March 31, 2025, underperforming the broader S&P 500 index, which rose 2.8% during...
SALT LAKE CITY, UT / ACCESS Newswire / April 29, 2025 / In the first calendar quarter (1Q) of 2025, Utah Medical Products, Inc. (Nasdaq:UTMD) attained financial results consistent with its previously announced...
SALT LAKE CITY, UT / ACCESS Newswire / February 4, 2025 / Utah Medical Products, Inc. (Nasdaq:UTMD) announces that its Board of Directors approved a quarterly cash dividend of thirty cents ($.305) per...
Shares of Utah Medical Products, Inc. UTMD have declined 4.6% since the company reported its earnings for the quarter ended Dec. 31, 2024. This compares to the S&P 500 index’s 0.5% growth over the same...